Predicting excellent response to radioiodine in differentiated thyroid cancer using machine learning

被引:0
|
作者
Bulbul, Ogun [1 ]
Nak, Demet [1 ]
机构
[1] Recep Tayyip Erdogan Univ, Training & Res Hosp, Fac Med, Dept Nucl Med, Rize, Turkiye
关键词
machine learning; excellent response; prediction; radioactive iodine; differentiated thyroid cancer; RADIOACTIVE IODINE THERAPY; REMNANT ABLATION; INTERMEDIATE-RISK; THYROGLOBULIN; SURVIVAL; CARCINOMA; FAILURE; IMPACT;
D O I
10.14639/0392-100X-N3029
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective. If excellent response (ER) occurs after radioactive iodine (RAI) treatment in patients with differentiated thyroid carcinoma (DTC), the recurrence rate is low. Our study aims to predict ER at 6-24 months after RAI I by using machine learning (ML) methods in which clinicopathological parameters are included in patients with DTC without distant metastasis. Methods. Treatment response of 151 patients with DTC without distant metastasis and who received RAI treatment was determined (ER/nonER). Thyroidectomy +/- neck dissection pathology data, laboratory, and imaging findings before and after RAI treatment were introduced to ML models. Results. After RAI treatment, 118 patients had ER and 33 had nonER. Before RAI treatment, TgAb was positive in 29% of patients with ER and 55% of patients with nonER (p = 0.007). Eight of the ML models predicted ER with high area under the ROC curve (AUC) values (> 0.700). The model with the highest AUC value was extreme gradient boosting (AUC = 0.871), the highest accuracy shown by gradient boosting (81%). Conclusions. ML models may be used to predict ER in patients with DTC without distant metastasis.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 50 条
  • [41] Assessment of radioiodine clearance in patients with differentiated thyroid cancer
    Tabei, Faraj
    Asli, Isa Neshandar
    Azizmohammadi, Zahra
    Javadi, Hamid
    Assadi, Majid
    RADIATION PROTECTION DOSIMETRY, 2012, 152 (04) : 323 - 327
  • [42] Random Forest for Predicting Treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid Cancer But Without Structural Disease
    Sa, Ri
    Yang, Taiyu
    Zhang, Zexu
    Guan, Feng
    ONCOLOGIST, 2024, 29 (01): : e68 - e80
  • [43] Predictive factors determining incomplete response to radioiodine therapy in patients with differentiated thyroid cancer
    Szczepanek-Parulska, Ewelina
    Wojewoda-Korbelak, Magdalena
    Borowczyk, Martyna
    Kaluzna, Malgorzata
    Brominska, Barbara
    Ziemnicka, Katarzyna
    Czepczynski, Rafal
    Baczyk, Maciej
    Ruchala, Marek
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (01): : 115 - 123
  • [44] Creating Prognostic Systems for Well-Differentiated Thyroid Cancer Using Machine Learning
    Yang, Charles Q.
    Gardiner, Lauren
    Wang, Huan
    Hueman, Matthew T.
    Chen, Dechang
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [45] Thyroglobulin Flare Response After Radioiodine Ablation in 2 Patients With Differentiated Thyroid Cancer
    Tsang, James F.
    Levin, Daniel P.
    Leslie, William D.
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (05) : 421 - 422
  • [46] Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer
    Lin, Yansong
    Wang, Chen
    Gao, Wen
    Cui, Ruixue
    Liang, Jun
    ONCOTARGET, 2017, 8 (26) : 42252 - 42261
  • [47] Age & puberty are major determinants of response to radioiodine in children and adolescents with differentiated thyroid cancer
    Singh, S. S.
    Sood, A.
    Bhattacharya, A.
    Mittal, B. R.
    Kumar, G.
    Shekhawat, A. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S329 - S330
  • [48] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    Castagna, M. G.
    Cantara, S.
    Pacini, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (10) : 1087 - 1094
  • [49] Radioiodine Imaging for Differentiated Thyroid Cancer: Not All Radioiodine Images Are Performed Equally
    Van Nostrand, Douglas
    THYROID, 2019, 29 (07) : 901 - 909
  • [50] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    M. G. Castagna
    S. Cantara
    F. Pacini
    Journal of Endocrinological Investigation, 2016, 39 : 1087 - 1094